Brands: Pentasa · Mesalamine
Average across 2 priced NDCs. A benchmark of pharmacy acquisition cost - not a retail quote.
Prescriptions dispensed under Medicaid (fee-for-service + managed care), summed nationally. The closest free proxy to sales volume - Medicaid only, not all-payer.
US labelers as registered with FDA. Repackagers relabel another company's product; share* is of listed packages, not sales.
| Labeler | Type | Packages | Status |
|---|---|---|---|
| Takeda Pharmaceuticals America, Inc. | unknown | 2 | SUPPLYING |
Shortages, recalls, and registration changes attached to this drug concept.
Mesalamine Capsule, Extended Release — reported in shortage by Takeda Pharmaceuticals USA Inc.. Therapeutic category: Gastroenterology.
Mesalamine Capsule, Extended Release — reported in shortage by Takeda Pharmaceuticals USA Inc.. Therapeutic category: Gastroenterology.
Presence of Foreign Tablets/Capsules; 500 mg capsules were found in bottles labeled to contain 250 mg capsules — Recalling firm: Shire PLC — Nationwide and Puerto Rico
